IL320996A - Negative nmda-modulating compounds and methods of use thereof - Google Patents

Negative nmda-modulating compounds and methods of use thereof

Info

Publication number
IL320996A
IL320996A IL320996A IL32099625A IL320996A IL 320996 A IL320996 A IL 320996A IL 320996 A IL320996 A IL 320996A IL 32099625 A IL32099625 A IL 32099625A IL 320996 A IL320996 A IL 320996A
Authority
IL
Israel
Prior art keywords
nmda
negative
methods
modulating compounds
modulating
Prior art date
Application number
IL320996A
Other languages
Hebrew (he)
Original Assignee
Sage Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sage Therapeutics Inc filed Critical Sage Therapeutics Inc
Publication of IL320996A publication Critical patent/IL320996A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/008—3 membered carbocyclic rings in position 15/16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
IL320996A 2022-11-21 2023-11-21 Negative nmda-modulating compounds and methods of use thereof IL320996A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263427012P 2022-11-21 2022-11-21
PCT/US2023/080694 WO2024112759A1 (en) 2022-11-21 2023-11-21 Negative nmda-modulating compounds and methods of use thereof

Publications (1)

Publication Number Publication Date
IL320996A true IL320996A (en) 2025-07-01

Family

ID=89385897

Family Applications (1)

Application Number Title Priority Date Filing Date
IL320996A IL320996A (en) 2022-11-21 2023-11-21 Negative nmda-modulating compounds and methods of use thereof

Country Status (10)

Country Link
EP (1) EP4622987A1 (en)
JP (1) JP2025538551A (en)
KR (1) KR20250124139A (en)
CN (1) CN120882732A (en)
AR (1) AR131116A1 (en)
AU (1) AU2023385734A1 (en)
IL (1) IL320996A (en)
MX (1) MX2025005846A (en)
TW (1) TW202430133A (en)
WO (1) WO2024112759A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
CN107936076B (en) * 2011-09-08 2021-10-15 萨奇治疗股份有限公司 Neuroactive steroids, compositions, and uses thereof
AU2014256229B2 (en) 2013-04-17 2018-10-04 Sage Therapeutics, Inc. 19-nor C3,3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof
US11111266B2 (en) * 2016-10-18 2021-09-07 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
TW202143976A (en) * 2020-03-18 2021-12-01 美商賽吉醫療公司 Neuroactive steroids and their methods of use

Also Published As

Publication number Publication date
KR20250124139A (en) 2025-08-19
WO2024112759A1 (en) 2024-05-30
AR131116A1 (en) 2025-02-19
MX2025005846A (en) 2025-08-01
EP4622987A1 (en) 2025-10-01
AU2023385734A1 (en) 2025-06-26
JP2025538551A (en) 2025-11-28
CN120882732A (en) 2025-10-31
TW202430133A (en) 2024-08-01

Similar Documents

Publication Publication Date Title
IL314320A (en) Compounds and methods of use
IL312348A (en) Inhibitors of hif-2alpha and methods of use thereof
IL299245A (en) Lair-1-binding agents and methods of use thereof
IL316619A (en) Pi3kα inhibitors and methods of use thereof
IL316368A (en) Anti-tl1a antibodies and methods of use thereof
CA3262145A1 (en) Aza-quinazoline compounds and methods of use
ZA202208598B (en) Isoform-selective anti-tgf-beta antibodies and methods of use
CA3253801A1 (en) N6-adenosine-methyltransferase protacs and methods of use thereof
IL314594A (en) Heterocyclic compounds and methods of use
CA3266793A1 (en) Anti-b7h3 antibodies and methods of use
IL317690A (en) Anti-gpnmb antibodies and methods of use thereof
IL318694A (en) Anti-ccr8 antibodies and methods of use
IL315845A (en) Anti-dectin-1 antibodies and methods of use thereof
IL323285A (en) Anti-phosphocholine antibodies and methods of use thereof
CA3248844A1 (en) Anti-b7-h3 compounds and methods of use
IL320996A (en) Negative nmda-modulating compounds and methods of use thereof
IL299163A (en) Macrocyclic compounds and methods of use thereof
IL277528B (en) Herbicidal compounds and methods of use thereof
CA3268418A1 (en) Multispecific antibodies and methods of use thereof
CA3259194A1 (en) Aldh-2 inhibitor compounds and methods of use
CA3253413A1 (en) Pyrimidopyrimidone compounds and methods of use thereof
GB202315697D0 (en) Compounds and methods of use
IL314338A (en) Anti-b7-h3 compounds and methods of use
GB202212937D0 (en) Compounds and methods of use
GB202119051D0 (en) Wingsail and method of use